147 related articles for article (PubMed ID: 27167908)
1. Interleukins (ILs), a fascinating family of cytokines. Part II: ILs from IL-20 to IL-38.
Fietta P; Costa E; Delsante G
Theor Biol Forum; 2015; 108(1-2):19-40. PubMed ID: 27167908
[TBL] [Abstract][Full Text] [Related]
2. Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19.
Fietta P; Costa E; Delsante G
Theor Biol Forum; 2014; 107(1-2):13-45. PubMed ID: 25936211
[TBL] [Abstract][Full Text] [Related]
3. Natural products modulating interleukins and other inflammatory mediators in tumor-bearing animals: A systematic review.
Gandhi GR; Antony PJ; Lana MJMP; da Silva BFX; Oliveira RV; Jothi G; Hariharan G; Mohana T; Gan RY; Gurgel RQ; Cipolotti R; Quintans LJ
Phytomedicine; 2022 Jun; 100():154038. PubMed ID: 35358934
[TBL] [Abstract][Full Text] [Related]
4. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.
Akdis M; Burgler S; Crameri R; Eiwegger T; Fujita H; Gomez E; Klunker S; Meyer N; O'Mahony L; Palomares O; Rhyner C; Ouaked N; Schaffartzik A; Van De Veen W; Zeller S; Zimmermann M; Akdis CA
J Allergy Clin Immunol; 2011 Mar; 127(3):701-21.e1-70. PubMed ID: 21377040
[TBL] [Abstract][Full Text] [Related]
5. Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases.
Zhao Y; Wang H; Jin L; Zhang Z; Liu L; Zhou M; Zhang X; Zhang L
Eur J Pharm Sci; 2024 Jan; 192():106647. PubMed ID: 37984595
[TBL] [Abstract][Full Text] [Related]
6. The growing spectrum of anti-inflammatory interleukins and their potential roles in the development of sepsis.
Zhao HQ; Li WM; Lu ZQ; Sheng ZY; Yao YM
J Interferon Cytokine Res; 2015 Apr; 35(4):242-51. PubMed ID: 25517926
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune Neuroinflammatory Diseases: Role of Interleukins.
Khan AW; Farooq M; Hwang MJ; Haseeb M; Choi S
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175665
[TBL] [Abstract][Full Text] [Related]
8. Interleukin role in the regulation of endothelial cell pathological activation.
Carbone ML; Failla CM
Vasc Biol; 2021; 3(1):R96-R105. PubMed ID: 34870094
[TBL] [Abstract][Full Text] [Related]
9. Targeting IL-33 in autoimmunity and inflammation.
Theoharides TC; Petra AI; Taracanova A; Panagiotidou S; Conti P
J Pharmacol Exp Ther; 2015 Jul; 354(1):24-31. PubMed ID: 25906776
[TBL] [Abstract][Full Text] [Related]
10. Interleukins and Ischemic Stroke.
Zhu H; Hu S; Li Y; Sun Y; Xiong X; Hu X; Chen J; Qiu S
Front Immunol; 2022; 13():828447. PubMed ID: 35173738
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of IL-34 in neurodegenerative and neurological infectious disease.
Chhetri G
Int J Neurosci; 2023 Jun; 133(6):660-671. PubMed ID: 34347576
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary divergence and functions of the human interleukin (IL) gene family.
Brocker C; Thompson D; Matsumoto A; Nebert DW; Vasiliou V
Hum Genomics; 2010 Oct; 5(1):30-55. PubMed ID: 21106488
[TBL] [Abstract][Full Text] [Related]
13. [Cytokines and the liver in health and disease].
Kolarski V; Todorov A; Petrova D
Vutr Boles; 2000; 32(1):19-24. PubMed ID: 11195192
[TBL] [Abstract][Full Text] [Related]
14. Interleukins in liver disease treatment.
Yang M; Zhang CY
World J Hepatol; 2024 Feb; 16(2):140-145. PubMed ID: 38495285
[TBL] [Abstract][Full Text] [Related]
15. Interleukin pattern of Apert fibroblasts in vitro.
Bodo M; Carinci F; Baroni T; Becchetti E; Bellucci C; Giammarioli M; Pezzetti F; Tognon M; Carinci P
Eur J Cell Biol; 1998 Apr; 75(4):383-8. PubMed ID: 9628325
[TBL] [Abstract][Full Text] [Related]
16. IL-17 and IL-22: siblings, not twins.
Eyerich S; Eyerich K; Cavani A; Schmidt-Weber C
Trends Immunol; 2010 Sep; 31(9):354-61. PubMed ID: 20691634
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
18. Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).
Conti P; Youinou P; Theoharides TC
Autoimmun Rev; 2007 Jan; 6(3):131-7. PubMed ID: 17289547
[TBL] [Abstract][Full Text] [Related]
19. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
